drugset / Trial / NCT01605370
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate if a drug called nebivolol can reverse inappropriate left ventricular mass (LVM) when compared to the standard of care drug metoprolol.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metoprolol | Other / unclassified | 50 mg | — |
| Subject | Nebivolol | Other / unclassified | 2.5 mg | — |